Do we really know who has an <i>MGMT</i> methylated glioma? Results of an international survey regarding use of <i>MGMT</i> analyses for glioma.

Malmström, Annika; Lysiak, Malgorzata; Kristensen, Bjarne Winther; Hovey, Elizabeth; Henriksson, Roger; Söderkvist, Peter

Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma.

Malmström, Annika; Lysiak, Malgorzata; Kristensen, Bjarne Winther; Hovey, Elizabeth; Henriksson, Roger; Söderkvist, Peter.

Afiliação

Malmström A; Department of Advanced Home Care, Linköping University, Sweden.
Lysiak M; Department of Clinical and Experimental Medicine, Linköping University, Sweden.
Kristensen BW; Department of Clinical and Experimental Medicine, Linköping University, Sweden.
Hovey E; Department of Pathology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark.
Henriksson R; Department of Medical Oncology, Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia.
Söderkvist P; University of New South Wales, Sydney, Australia.

Neurooncol Pract ; 7(1): 68-76, 2020 Jan.

Article em En | MEDLINE | ID: mdl-32025325

Palavras-chave

MGMT testing; glioma; international consensus guidelines; international survey; laboratory methods and cutoff level

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Neurooncol Pract Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suécia País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google